nicardipine has been researched along with Vascular Diseases in 3 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicardipine is a safe and effective alternative of verapamil in preventing spasm of radial artery conduit." | 6.90 | Preventing spasm of the radial artery conduit during coronary artery bypass grafting: Nicardipine versus verapamil. ( Haanschoten, M; Özdemir, AB; Özdemir, HI; Soliman-Hamad, MA; van Dijk, CHB; van Straten, BHM, 2019) |
| "Nicardipine is a safe and effective alternative of verapamil in preventing spasm of radial artery conduit." | 2.90 | Preventing spasm of the radial artery conduit during coronary artery bypass grafting: Nicardipine versus verapamil. ( Haanschoten, M; Özdemir, AB; Özdemir, HI; Soliman-Hamad, MA; van Dijk, CHB; van Straten, BHM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özdemir, HI | 1 |
| van Dijk, CHB | 1 |
| Özdemir, AB | 1 |
| van Straten, BHM | 1 |
| Haanschoten, M | 1 |
| Soliman-Hamad, MA | 1 |
| Renard, C | 1 |
| Baumann, D | 1 |
| Thiriat, S | 1 |
| Debliquis, A | 1 |
| Lindner, V | 1 |
| Thiébault, S | 1 |
1 trial available for nicardipine and Vascular Diseases
| Article | Year |
|---|---|
Preventing spasm of the radial artery conduit during coronary artery bypass grafting: Nicardipine versus verapamil.
Topics: Administration, Topical; Calcium Channel Blockers; Coronary Artery Bypass; Female; Humans; Linear Mo | 2019 |
2 other studies available for nicardipine and Vascular Diseases
| Article | Year |
|---|---|
[Isolated splenic peliosis: a case report].
Topics: Aged; Anemia; Ankle Injuries; Antigens, Differentiation; CD8 Antigens; Diagnostic Errors; Endothelia | 2012 |
Management and clinical use of intravenous nicarpidine. Presented at the 35th annual meeting of the American College of Angiology. Orlando, Florida, October, 1988. Proceedings.
Topics: Animals; Humans; Infusions, Intravenous; Nicardipine; Vascular Diseases | 1990 |